Treatment of a Hemophilia B Mouse Model with Platelet-Targeted Expression of Factor IX Padua-Reference-Cited by-同舟云学术

Treatment of a Hemophilia B Mouse Model with Platelet-Targeted Expression of Factor IX Padua

Published:2021-05-01 Issue:9-10 Volume:32 Page:506-516
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Li Binbin¹,Wu Zhihan¹,Xu Wenjue¹,Han Wenwen¹,Liu Jiayu¹,Wang Dawei²³^ORCID,Zhang Guowei¹^ORCID

Affiliation:

1. Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Department of Basic Medical Sciences, Hangzhou Normal University School of Medicine, Hangzhou, China.

2. National Research Center for Translational Medicine, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

3. State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2020.309

Reference39 articles.

1. Novel approaches to hemophilia therapy: successes and challenges

2. Bittersweet progress for haemophilia A

3. Modern haemophilia care

4. Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

5. Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of FXa-storing platelets in hemophilia B mice and the influence of alcohol on the platelets;Scientific Reports;2023-10-01

2. Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models;Frontiers in Veterinary Science;2022-03-28